Cytokinetics, Inc. (CYTK)
62.99
-0.32
(-0.51%)
USD |
NASDAQ |
Oct 30, 16:00
63.15
+0.16
(+0.25%)
Pre-Market: 20:00
Cytokinetics 30-Day Average Daily Volume : 1.850M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.850M |
| October 29, 2026 | 1.970M |
| October 28, 2026 | 1.969M |
| October 27, 2026 | 2.001M |
| October 26, 2026 | 2.048M |
| October 23, 2026 | 2.073M |
| October 22, 2026 | 2.098M |
| October 21, 2026 | 2.077M |
| October 20, 2026 | 2.089M |
| October 19, 2026 | 2.118M |
| October 16, 2026 | 2.092M |
| October 15, 2026 | 2.105M |
| October 14, 2026 | 2.103M |
| October 13, 2026 | 2.096M |
| October 12, 2026 | 2.134M |
| October 09, 2026 | 2.238M |
| October 08, 2026 | 2.238M |
| October 07, 2026 | 2.192M |
| October 06, 2026 | 2.155M |
| October 05, 2026 | 2.087M |
| October 02, 2026 | 2.030M |
| October 01, 2026 | 1.997M |
| September 30, 2026 | 1.990M |
| September 29, 2026 | 1.945M |
| September 28, 2026 | 1.915M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.889M |
| September 24, 2026 | 1.894M |
| September 23, 2026 | 1.903M |
| September 22, 2026 | 1.877M |
| September 21, 2026 | 1.873M |
| September 18, 2026 | 1.940M |
| September 17, 2026 | 1.862M |
| September 16, 2026 | 1.868M |
| September 15, 2026 | 1.876M |
| September 14, 2026 | 1.865M |
| September 11, 2026 | 1.867M |
| September 10, 2026 | 1.879M |
| September 09, 2026 | 1.890M |
| September 08, 2026 | 1.898M |
| September 04, 2026 | 1.895M |
| September 03, 2026 | 1.912M |
| September 02, 2026 | 1.895M |
| September 01, 2026 | 1.910M |
| August 31, 2026 | 1.887M |
| August 28, 2026 | 1.834M |
| August 27, 2026 | 1.741M |
| August 26, 2026 | 1.751M |
| August 25, 2026 | 1.754M |
| August 24, 2026 | 1.760M |
| August 21, 2026 | 1.783M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Bristol Myers Squibb Co. | 12.72M |
| BridgeBio Pharma, Inc. | 2.958M |
| Alnylam Pharmaceuticals, Inc. | 1.861M |
| BioMarin Pharmaceutical, Inc. | 2.343M |
| Exelixis, Inc. | 2.250M |